Page last updated: 2024-08-24

imiquimod and Cancer of Prostate

imiquimod has been researched along with Cancer of Prostate in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (28.57)	29.6817
2010's	3 (42.86)	24.3611
2020's	2 (28.57)	2.80

Authors

Authors	Studies
Chen, J; Dong, S; Li, S; Lv, X; Wang, C; Wei, Q; Wu, J; Yang, N	1
Angel, M; Aparicio, B; Berzofsky, JA; Calvo, A; Egea, J; Lasarte, JJ; Llopiz, D; Redin, E; Repáraz, D; Ruiz, M; Sarobe, P; Silva, L; Stroncek, D	1
Cho, SD; Choi, ES; Han, JH; Jeon, SJ; Kim, BY; Kim, DJ; Lee, J; Park, JH	1
Battaglia, F; Boccardo, F; Carmignani, G; Cittadini, G; Criscuolo, D; Fenoglio, D; Ferrera, F; Filaci, G; Indiveri, F; Kalli, F; Murdaca, G; Negrini, S; Parodi, A; Puppo, F; Sciallero, S; Setti, M; Sobrero, A; Tomasello, L; Traverso, P	1
Cho, SD; Han, JH; Kang, MJ; Kim, B; Kim, BY; Kim, DJ; Kim, JB; Park, JH; Park, SY	1
Bedke, J; Dietz, K; Feyerabend, S; Gouttefangeas, C; Hennenlotter, J; Kuczyk, M; Pascolo, S; Rammensee, HG; Stenzl, A; Stevanovic, S; Wernet, D	1
Festa Neto, C; Niwa, AB; Sanches, JA; Tanaka, VD; Torezan, L	1

Trials

1 trial(s) available for imiquimod and Cancer of Prostate

Article	Year
Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancer. The Prostate, 2009, Jun-15, Volume: 69, Issue:9 Topics: Aged; Aminoquinolines; Antigens, Neoplasm; Antineoplastic Agents; Cancer Vaccines; Combined Modality Therapy; Drug Resistance, Neoplasm; Granulocyte-Macrophage Colony-Stimulating Factor; HLA-A2 Antigen; Hormones; Humans; Hyperthermia, Induced; Imiquimod; Magnetic Resonance Imaging; Male; Mannitol; Middle Aged; Mucin-1; Oleic Acids; Peptide Fragments; Prostate-Specific Antigen; Prostatic Neoplasms; Protamines; RNA, Messenger; Secondary Prevention; Tomography, X-Ray Computed	2009

Article

Year

Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancer.

The Prostate, 2009, Jun-15, Volume: 69, Issue:9

Topics: Aged; Aminoquinolines; Antigens, Neoplasm; Antineoplastic Agents; Cancer Vaccines; Combined Modality Therapy; Drug Resistance, Neoplasm; Granulocyte-Macrophage Colony-Stimulating Factor; HLA-A2 Antigen; Hormones; Humans; Hyperthermia, Induced; Imiquimod; Magnetic Resonance Imaging; Male; Mannitol; Middle Aged; Mucin-1; Oleic Acids; Peptide Fragments; Prostate-Specific Antigen; Prostatic Neoplasms; Protamines; RNA, Messenger; Secondary Prevention; Tomography, X-Ray Computed

2009

Other Studies

6 other study(ies) available for imiquimod and Cancer of Prostate

Article	Year
Surgically Derived Cancer Cell Membrane-Coated R837-Loaded Poly(2-Oxazoline) Nanoparticles for Prostate Cancer Immunotherapy. ACS applied materials & interfaces, 2023, Feb-15, Volume: 15, Issue:6 Topics: Antigens, Neoplasm; Cancer Vaccines; Cell Line, Tumor; Cell Membrane; Dendritic Cells; Humans; Imiquimod; Immunotherapy; Male; Nanoparticles; Prostatic Neoplasms	2023
Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy. Cancer letters, 2021, 02-28, Volume: 499 Topics: Adjuvants, Immunologic; Animals; Axl Receptor Tyrosine Kinase; c-Mer Tyrosine Kinase; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Dendritic Cells; Female; Gene Expression Regulation, Neoplastic; Humans; Imiquimod; Immunogenicity, Vaccine; Immunotherapy; Interleukin-10; Lymphocytes, Tumor-Infiltrating; Male; Melanoma, Experimental; Mice; Mice, Transgenic; Poly I-C; Prostatic Neoplasms; Proto-Oncogene Proteins; Pyrimidines; Quinolines; Receptor Protein-Tyrosine Kinases; Up-Regulation	2021
In vitro and in vivo growth inhibition of prostate cancer by the small molecule imiquimod. International journal of oncology, 2013, Volume: 42, Issue:6 Topics: Aminoquinolines; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Chloroquine; Cyclin B1; Humans; Imiquimod; Injections, Intralesional; Male; Mice; Mice, Inbred C57BL; Mitochondria; Prostatic Neoplasms; Toll-Like Receptor 7; Xenograft Model Antitumor Assays	2013
A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer. Cancer immunology, immunotherapy : CII, 2013, Volume: 62, Issue:6 Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Antigens, Neoplasm; Cancer Vaccines; Cell Proliferation; Combined Modality Therapy; Cytotoxicity, Immunologic; Humans; Imiquimod; Interferon-gamma; Kidney Neoplasms; Male; Mannitol; Middle Aged; Neoplasm Staging; Oleic Acids; Peptides; Phenotype; Prostatic Neoplasms; Telomerase; Treatment Outcome	2013
TLR7 expression is decreased during tumour progression in transgenic adenocarcinoma of mouse prostate mice and its activation inhibits growth of prostate cancer cells. American journal of reproductive immunology (New York, N.Y. : 1989), 2013, Volume: 70, Issue:4 Topics: Adenocarcinoma; Aminoquinolines; Animals; Antineoplastic Agents; Carcinogenesis; Cell Growth Processes; Cell Line, Tumor; Cytokines; Disease Models, Animal; Disease Susceptibility; Epithelial Cells; Gene Expression Regulation, Neoplastic; Guanosine; Humans; Imiquimod; Inflammation Mediators; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Prostate; Prostatic Neoplasms; Toll-Like Receptor 7; Transgenes; Tumor Stem Cell Assay	2013
Mammary and extramammary Paget's disease: a study of 14 cases and the associated therapeutic difficulties. Clinics (Sao Paulo, Brazil), 2009, Volume: 64, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Male; Middle Aged; Paget Disease, Extramammary; Paget's Disease, Mammary; Prostatic Neoplasms; Vulvar Neoplasms	2009